Log in to save to my catalogue

Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy cha...

Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy cha...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1753480482

Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth

About this item

Full title

Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth

Publisher

Berlin/Heidelberg: Springer-Verlag

Journal title

Journal of cancer research and clinical oncology, 2012-07, Vol.138 (7), p.1205-1220

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer-Verlag

More information

Scope and Contents

Contents

Background
Proteins involved in the aberrant regulation of signaling pathways and their downstream effectors are promising targets for cancer therapy. Survivin is an anti-apoptotic and cell cycle-promoting protein, which is consistently overexpressed in cancer cells. In normal cells, its expression is tightly controlled by signaling pathways and...

Alternative Titles

Full title

Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1753480482

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1753480482

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-012-1195-1

How to access this item